Your browser doesn't support javascript.
loading
Can toxicities induced by antituberculosis drugs be better managed in diabetic patients?
Yew, Wing Wai; Chan, Denise P; Leung, Chi Chiu; Zhang, Ying; Wang, Ruibing; Ng, Phoebe; Lee, Simon M.
Afiliação
  • Yew WW; Stanley Ho Centre for Emerging Infectious Diseases, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
  • Chan DP; Stanley Ho Centre for Emerging Infectious Diseases, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China denisechan@cuhk.edu.hk.
  • Leung CC; Tuberculosis and Chest Service, Centre for Health Protection, Department of Health, Hong Kong, China.
  • Zhang Y; Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
  • Wang R; State Key Laboratory of Quality Research in Chinese Medicine and Institute of Chinese Medical Sciences, University of Macau, Macao, China.
  • Ng P; State Key Laboratory of Quality Research in Chinese Medicine and Institute of Chinese Medical Sciences, University of Macau, Macao, China.
  • Lee SM; State Key Laboratory of Quality Research in Chinese Medicine and Institute of Chinese Medical Sciences, University of Macau, Macao, China.
Eur Respir J ; 50(1)2017 07.
Article em En | MEDLINE | ID: mdl-28729475

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus / Tuberculose Extensivamente Resistente a Medicamentos / Antituberculosos Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus / Tuberculose Extensivamente Resistente a Medicamentos / Antituberculosos Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article